Fundraising Fox
/Companies
Sign in

TargED Biopharmaceuticals

Utrecht, NL · Founded 2018 · 40 employees on LinkedIn · 11 known investors

Find your way into TargED Biopharmaceuticals

Sign up to see every warm intro you have to TargED Biopharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the TargED Biopharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht. The company focuses on bringing novel compounds from early-stage research to clinical development.

BiotechMedical Devices

Founders & leadership

TargED Biopharmaceuticals was founded in 2018 by Coen Maas, Steven de Maat, Marc van Moorsel, and Kristof Vercruysse.

CMCoen Maas
Coen MaasCo-founderCoen Maas is a researcher with extensive publications in his field, having authored or co-authored over 100 peer-reviewed articles and supervised multiple doctoral candidates. He is co-founder of TargED Biopharmaceuticals, a spinout from University Medical Center Utrecht developing therapeutics for thrombotic disorders.
SDSteven de Maat
Steven de MaatChief Scientific OfficerSteven de Maat holds a PhD and has conducted research on bradykinin production and microvascular thrombosis, leading to work on selective modification of SERPINs for therapeutic applications in bradykinin-mediated disease. He co-founded TargED Biopharmaceuticals (formerly SERPINx BV) and currently serves as Chief Scientific Officer.
MV
Marc van MoorselDirector of OperationsDirector of Operations at TargED Biopharmaceuticals, a biopharmaceutical company developing therapeutics for thrombotic disorders that was spun out from University Medical Center Utrecht.
KVKristof Vercruysse
Kristof VercruysseChief Executive OfficerKristof Vercruysse is CEO of TargED Biopharmaceuticals, a biopharmaceutical company developing therapeutics for thrombotic disorders spun out from University Medical Center Utrecht. He has led the advancement of drug candidates from preclinical studies through human proof-of-concept trials and brings experience in pharmaceutical development strategy, project leadership, and orphan drug programs.
RDRob Dekker
Rob DekkerVice President CMCRob Dekker brings nearly 30 years of experience in pharmaceutical manufacturing science, regulatory strategy, and quality management. At TargED Biopharmaceuticals, he leads chemistry, manufacturing, and controls efforts for the company's thrombotic disorder therapeutics.
FV
Filip Van den WyngaertVice President Asset ManagementHe has held leadership roles in pharmaceutical and biotech development across multiple geographies and therapeutic stages, with experience in asset strategy and organizational scaling.
DSDr. Samuel White
Dr. Samuel WhiteChief Business Officer
JHJosi Holz
Josi HolzChief Medical OfficerJosi Holz completed medical oncology training at the University of Marburg and brings over 30 years of pharmaceutical drug development experience across Europe and North America, including more than two decades in executive roles overseeing translational medicine, clinical development, and regulatory strategy across oncology, immunology, hematology, and other therapeutic areas.

Investors · 11

BioGeneration Ventureslisted by BioGeneration VenturesNaarden

How we know: BioGeneration Ventures's portfolio page · a partner's Signal profile · funding news · prnewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Curie Capitallisted by Curie CapitalAmsterdam

How we know: prnewswire.com · Not right? Tell us

Fund+listed by Fund+Leuven · $5.5M – $16.5M

How we know: Fund+'s portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

Hadean Ventureslisted by Hadean VenturesOslo

How we know: Hadean Ventures's portfolio page · funding news · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

Inkeflisted by InkefAmsterdam

How we know: Inkef's portfolio page · a partner's Signal profile · funding news · prnewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Rotriplisted by RotripAmsterdam
Sunstone CapitalreportedFrederiksberg

How we know: the VCSheet dataset · Not right? Tell us

Also in the syndicate · 3

FIRSTSunstone Life Science VenturesUtrecht Health Seed Fund

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Dutch-based TargED raises €21.5 million Series A extension to advance targeted treatments for thrombotic diseases | EU-Startupseu-startups.com · Dec 2025TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patientsprnewswire.com · Feb 2022

Frequently asked questions

What does TargED Biopharmaceuticals do?
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht. The company focuses on bringing novel compounds from early-stage research to clinical development.
Who founded TargED Biopharmaceuticals?
TargED Biopharmaceuticals was founded by Coen Maas, Steven de Maat, Marc van Moorsel, Kristof Vercruysse in 2018.
Who are TargED Biopharmaceuticals's investors?
TargED Biopharmaceuticals's investors include Andera Partners, BioGeneration Ventures, Curie Capital, Fund+, Hadean Ventures, Inkef, Rotrip, Sunstone Capital.
Where is TargED Biopharmaceuticals headquartered?
TargED Biopharmaceuticals is headquartered in Utrecht, NL.